Guillain-Barré syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: A case report and review of the literature

Kamal K.S. Abbi; Syed M. Rizvi; Jeffrey Sivik; Thyagarajan Subramanian; Thomas Loughran; Joseph Drabick

doi:10.1016/j.leukres.2010.02.036

Guillain-Barré syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: A case report and review of the literature

Kamal K.S. Abbi
, Syed M. Rizvi
, Jeffrey Sivik
, Thyagarajan Subramanian
, Thomas Loughran
, Joseph Drabick

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	e154-e156
Journal	Leukemia Research
Volume	34
Issue number	7
DOIs	https://doi.org/10.1016/j.leukres.2010.02.036
State	Published - Jul 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.leukres.2010.02.036

Cite this

@article{24a2e4d47d31456c8734059bb09bd676,

title = "Guillain-Barr{\'e} syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: A case report and review of the literature",

author = "Abbi, \{Kamal K.S.\} and Rizvi, \{Syed M.\} and Jeffrey Sivik and Thyagarajan Subramanian and Thomas Loughran and Joseph Drabick",

year = "2010",

month = jul,

doi = "10.1016/j.leukres.2010.02.036",

language = "English (US)",

volume = "34",

pages = "e154--e156",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd",

number = "7",

}

TY - JOUR

T1 - Guillain-Barré syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia

T2 - A case report and review of the literature

AU - Abbi, Kamal K.S.

AU - Rizvi, Syed M.

AU - Sivik, Jeffrey

AU - Subramanian, Thyagarajan

AU - Loughran, Thomas

AU - Drabick, Joseph

PY - 2010/7

Y1 - 2010/7

UR - https://www.scopus.com/pages/publications/77952981525

UR - https://www.scopus.com/pages/publications/77952981525#tab=citedBy

U2 - 10.1016/j.leukres.2010.02.036

DO - 10.1016/j.leukres.2010.02.036

M3 - Letter

C2 - 20362332

AN - SCOPUS:77952981525

SN - 0145-2126

VL - 34

SP - e154-e156

JO - Leukemia Research

JF - Leukemia Research

IS - 7

ER -

Guillain-Barré syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: A case report and review of the literature

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this